Viewing Study NCT00421304


Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2026-04-13 @ 7:45 PM
Study NCT ID: NCT00421304
Status: COMPLETED
Last Update Posted: 2021-08-27
First Post: 2007-01-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness
Sponsor: MedImmune LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None RSV Illness in ≤12 Months of Participants View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Respiratory Syncytial Virus illness View
None RSV View